These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Jiang H, Liu Y, Guo H, Liu Z, Li Z. BMC Cardiovasc Disord; 2024 May 03; 24(1):234. PubMed ID: 38702615 [Abstract] [Full Text] [Related]
29. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A. Int J Cardiovasc Imaging; 2017 Oct 03; 33(10):1463-1472. PubMed ID: 28444549 [Abstract] [Full Text] [Related]
30. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients. Zhang W, Chang G, Cao L, Ding G. BMC Cardiovasc Disord; 2021 Feb 05; 21(1):74. PubMed ID: 33546604 [Abstract] [Full Text] [Related]
31. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up. Zhao C, Yang L, Mao L, Zhong L, Li X, Wei S. Coron Artery Dis; 2013 Aug 05; 24(5):357-60. PubMed ID: 23835667 [Abstract] [Full Text] [Related]
34. CHA2DS2-Vasc score and CHA2DS2-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents. Zhao SG, Xu JJ, Tao ZH, Jin L, Liu Q, Zheng WY, Jiang LQ, Wang NF. J Int Med Res; 2019 Jun 05; 47(6):2533-2544. PubMed ID: 31039653 [Abstract] [Full Text] [Related]
35. The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation. Isodono K, Fujii K, Fujimoto T, Kasahara T, Ariyoshi M, Irie D, Tsubakimoto Y, Sakatani T, Matsuo A, Inoue K, Fujita H. Int J Cardiovasc Imaging; 2021 Jan 05; 37(1):15-23. PubMed ID: 32734495 [Abstract] [Full Text] [Related]
37. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T. Atherosclerosis; 2018 Feb 05; 269():197-203. PubMed ID: 29366993 [Abstract] [Full Text] [Related]
38. Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis. Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y. Catheter Cardiovasc Interv; 2015 Mar 05; 85(4):564-72. PubMed ID: 25158217 [Abstract] [Full Text] [Related]
39. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction. Li H, Zhang P, Li F, Yuan G, Wang X, Zhang A, Li F. Biomed Res Int; 2019 Mar 05; 2019():5012648. PubMed ID: 31179325 [Abstract] [Full Text] [Related]
40. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents. Alfonso F, Pérez-Vizcayno MJ, Cuesta J, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Cequier A, Velázquez M, Moreno R, Mainar V, Domínguez A, Moris C, Molina E, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández-Pérez C, RIBS IV Study Investigators (Under the Auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology). JACC Cardiovasc Interv; 2018 May 28; 11(10):981-991. PubMed ID: 29798776 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]